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Macroscopic hematuria in mesangial IgA nephropathy: Correlation
with glomerular crescents and renal dysfunction. One hundred and
eighty-six renal biopsy specimens from 79 adult patients with mesangial
IgA nephropathy were examined and correlated with clinical data at the
time of biopsy. Forty patients (group 1) with a history of macroscopic
hematuria were compared with 39 patients (group 2) without such a
history. Group I patients had a higher serum creatinine, 240 20
moles/liter vs. 140 10 moles/liter (P < 0.01), lower creatinine
clearance 69 36 mI/mm vs. 87 30 mI/mm (P < 0.05), and a higher
percentage of patients presenting with serum creatinine greater than 300
.tmolesIhter, 22.5% vs. 5.1% (P < 0.05). Fourteen biopsies were
performed in 11 patients during an episode of macroscopic hematuria
(group 1A). One hundred percent of these biopsy specimens showed
crescents. Ninety-one percent of 11 biopsy specimens from ten patients
(group 1B), taken 3 to 27 days following an episode but at a time when
urinary red cells were less than 1 ,000,000/ml, also showed crescent
formation. Of 14 biopsy specimens from 13 patients without macroscop-
ic hematuria, but with greater than I ,000,000 red cells/mi in the urine
just prior to biopsy (group 2A), 79% had crescents. In conclusion,
macroscopic hematuria in adult patients with mesangial IgA nephrop-
athy is associated with a high likelihood of crescents on renal biopsy
specimens and worse renal function. Careful quantitative assessment of
the urine for renal bleeding may help to better define the activity of
disease in these patients.
Hématurie macroscopique dans Ia néphropathie mésangiale a IgA:
Correlation avec les croissants glomérulaires et le dysfonctionnement
renal. Cent quatre vingt-six specimens de la biopsie rénale provenant de
79 malades adultes avec une nephropathie mésangiale a IgA ont été
examinées et corrélées aux données cliniques au moment de Ia biopsie.
Quarante malades (groupe I) avec une histoire d'hématurie macroscop-
ique ant été compares a 39 malades (groupe 2) sans cette histoire. Les
malades du groupe 1 avaient une créatininémie plus élevée, 240 20
moles/litre contre 140 10 j.tmoles/litre (P < 0,01), une clearance de Ia
créatinine plus faible, 69 36 mllmin contre 87 30 mllmin (P < 0,05),
et un plus fort pourcentage de malades ayant une créatininémie plus
élevée que 30 .tmoles/litre, 22,5% contre 5,1% (P < 0,05). Quatorze
biopsies ont été effectuées chez 11 malades pendant un episode
d'hématurie macroscopique (groupe IA). Cent pourcent de ces spéci-
mens de Ia biopsie montraient des croissants. Quatre-vingt-onze pour-
cent de 11 specimens de Ia biopsie provenant de dix malades (groupe
IB), faites 3 a 27 jours aprés un episode, mais a un moment les
hématies urinaires étaient a mains de 1.000.000/mi, montraient égale-
ment des formations en croissant. De 14 specimens de la biopsie
provenant de 13 malades sans hématurie macroscopique, mais avec
plus de 1.000.000 d'hématies/ml dans les urines juste avant Ia biopsie
(groupe 2A), 79% avaient des croissants. Dans conclusion, l'hématurie
macroscopique chez des malades adultes ayant une néphropathie
niésangiale a IgA est associée a une grande frequence de croissants a
specimens de la biopsie rénale et a une mains bonne fonction rénale.
Une étude quantitative soigneuse des urines a Ia recherche d'un
saignement renal peut aider a mieux définir l'activité de Ia maladie chez
ces malades.
Mesangial IgA nephropathy is a common clinical pathologic
syndrome often accompanied by recurrent episodes of macro-
scopic hematuria. Since renal function has been thought to be
relatively well preserved for prolonged periods, these episodes
have been considered to be of little importance [1, 2]. Recently
Clarkson et a! emphasized the need for prolonged observation
of such patients since a gradual decline in renal function was
suggested in follow-up studies of 50 patients with characteristic
mesangial immunofluorescence for IgA and C3 [3]. These
authors and others have found only increased age, proteinuria,
and hypertension as variables predicting an overall worse
prognosis in this disease [3—6]. This study was designed to
correlate clinicopathologic features of patients with mesangial
IgA nephropathy and the presence or absence of macroscopic
hematuria. The striking association of macroscopic hematuria
with focal and segmental proliferation, segmental necrosis and
their consequences, namely glomerular crescent formation, are
well illustrated. In addition, renal function of patients with
macroscopic hematuria at the time of biopsy is worse than
similar patients without macroscopic hematuria.
Methods
One hundred and eighty-six renal biopsy specimens from 79
patients with mesangial IgA nephropathy were reviewed. Con-
secutive patients with this pathologic diagnosis starting back-
ward from June 30, 1981, were used. In all patients the
diagnosis was based on the presence of IgA in the glomerular
mesangium as the predominant immunoglobulin present. No
patient had any evidence of a systemic disease known to be
associated with glomerular IgA deposition. Specifically, there
was no evidence of systemic lupus erythematosis, Henoch-
Schonlein purpura, cirrhosis of the liver, or systemic vasculitis.
In patients in whom the first biopsy was done prior to 1970, the
diagnosis of mesangial IgA nephropathy became clear only on
subsequent biopsies when immunofluorescence was routinely
available. For a biopsy specimen to be included in the study, a
minimum of ten glomeruli were needed.
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Clinical data were ascertained from the patient's record at the
time of each biopsy. This included blood pressure and renal
function as measured by serum creatinine and creatinine clear-
ance corrected for body surface area. Values are expressed as
micromoles per liter and milliliters per minute, respectively.
One milligram per deciliter of serum creatinine equals 88
mo1es/liter. Quantitative estimation of daily urine protein
excretion and urinary red blood cell count within the 24 hr
preceding the biopsy were also noted. To quantitatively assess
hematuria, a 10-mi fresh urine sample was centrifuged for 5 mm
at x750g in a centrifuge with a swing-out head. From this, 9.5
ml of supernatant was removed, and the resuspended deposit
was examined in a Fuchs-Rusenthal chamber, using phase-
contrast microscopy (Olympus BH microscope equipped with
positive phase-contrast illumination).
In many patients whose biopsies were performed after 1975,
serum immunoglobulin A was measured by immunodiffusion.
Values greater than 4 mg/mI were considered to be elevated.
Circulating immune complexes were determined by modifica-
tion of the liquid phase Clq binding assay of Zubler and
Lambert [71. Percent binding greater than 4% was considered
abnormal. In all 79 patients, serum antistreptolysin 0 titer, C3,
C4, antinuclear factor and/or antibodies to DNA were normal or
negative. These tests were carried out with commercially
available immunodiffusion plates. Urologic causes for bleeding
were excluded by intravenous pyelography and cystoscopy in
most instances.
Renal biopsy specimens were fixed in Dubosq-Brazil solu-
tion, and 24 serial 1-2 sections were cut and stained with
hematoxylin and eosin, periodic acid Schiff, Masson's tn-
chrome, Silver-Masson, and Weigerts elastic and counter-
stained with von Gresoris connective tissue stain. Tissue was
snap-frozen and sectioned in cryostat at —20°C and stained by
the direct immunofluorescent method with fluorescein-labelled
antisera. Commercial antisera against IgG, IgA, 1gM, Clq, C3,
fibrogen, and albumin were used.
Although tissue samples were taken and preserved for elec-
tron microscopy, ultrastructural examination was only per-
formed on 20% of the biopsy specimens to confirm the typical
pattern of deposition of immunoglobulin or complexes suggest-
ed by light and immunofluorescent microscopy. Biopsy speci-
mens were examined for basic histologic pattern. Any superim-
posed focal or segmental proliferative hyalinotic and sclerotic
lesions as well as the percentage of glomeruli with crescents and
total sclerosis were recorded. The type of immunoglobulin or
complement deposition in addition to IgA was noted.
The histologic criteria for the designations used in this paper
were as follows:
When there was an increase in mesangial matrix and mesan-
gial cells, the designation diffuse mesangial proliferative (DMP)
glomerulonephritis was applied. Invariably red staining mesan-
gial deposits were prominent on trichrome stains and electron
dense deposits were noted when ultrastructural examinations
were performed.
When areas of focal and segmental proliferation were super-
imposed on the basic pattern, the biopsy specimen was classi-
fied as showing focal and segmental proliferative glomerulone-
phritis (Figs. 1 and 2). In these patients segmental crescents,
fibniliar fibrin deposits and necrosis were almost invariable as
was evidence of red blood cells in Bowman's space and within
tubular lumens (Fig. 3). The final superimposed histologic
pattern was focal and segmental hyalinosis and sclerosis (Fig.
4). This pattern was seen in conjunction with focal and segmen-
tal proliferative changes or in their absence. The degree of
interstitial fibrosis and vascular change was evaluated on a 1-to-
3-pius semi-quantitive basis. For purposes of analysis patients
were divided into two groups. Patients who had a well docu-
mented history of macroscopic hematuria were in group I
which included a total of 40 patients who underwent 116
biopsies: within group I were 14 biopsy specimens from 11
patients in whom biopsies were performed while their urine had
macroscopic hematuria and urinary red blood cell counts of
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Fig. 1. Large cellular crescent in a patient
with macroscopic hematuria. Fibrillar fibrin is
included in the crescent (arrow) which also
contains mitoses (double arrow). (Silver
Masson x900)lc44.— ,a-' ... -v
Fig. 2. Segmental area of sclerosis with
healing crescent (arrow) in a glomerulus
which also shows fibrillarfibrin related to a
break in the glomerular capillary wall (double
arrow). (Silver Masson x900)
Fig. 3. Biopsy specimen from a patient at the
time of macroscopic hematuria with many red
cells in Bowman's space and renal tubules.
The break in continuity of a glomerular
capillary (arrow) could be the source of this
glomerular hemorrhage. (Masson trichrome
x360)
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greater than 1,000,000 red blood cells/mi. These 11 patients are
considered separately as group iA. Another subset of 11 biopsy
specimens in ten patients, group lB, were taken within 30 days
of an episode of macroscopic hematuria, but at a time when
urinary red blood cells were less than 1,000,000 red blood cells/
ml and there was no further macroscopic hematuria evident.
Group 2 was comprised of 39 patients who had never had
macroscopic hematuria. Seventy biopsies were performed in
these patients. Within group 2 there were 13 patients who
underwent biopsy at a time when urinary red blood cell counts
were found to be greater than 1,000,000/mi, but macroscopic
hematuria had not been noted by either the patient or his
physician. This subset of 14 biopsy specimens in 13 patients
was designated by group 2A.
Groups 1 and 2 were compared in regard to the various
clinical and pathologic features by an unpaired t test or x2
analysis.
Results
In patients with macroscopic hematuria (group 1) there were
33 males and 7 females who presented at a mean age of 32.9
11.1 years. Group 2 had 25 males and 14 females with a mean
age of 37.1 11.7 years. Subgroups 1A, IB, and 2A had similar
ages of 34.6 16, 32.2 11, 36.6 15, respectively. Male to
female ratios in the subgroups were 8:3, 8:2, and 5:5, respec-
tively. None of the age and sex differences between groups or
subgroups reached statistical significance.
Characteristics of patients with macroscopic hematuria
(group 1) and without macroscopic hematuria (group 2) are
shown in Table 1.
The differences between the groups would be even more
striking if patients with microscopic hematuria of greater than
1,000,000 red blood cells/mi of urine (group 2A) were separated
from group 2 as a whole. The two patients without macroscopic
hematuria who presented with renal failure were both in sub-
group 2A. Eleven of the 14 biopsy specimens in the 13 patients
in this subgroup had crescents, and 13 of 14 had focal and
segmental proliferation. If these patients with heavy micro scop-
ic hematuria (greater than 106 red blood cells/ml) are compared
with the total group of patients without microscopic hematuria,
they have initial renal function and heavier proteinuria (P <
0.05). Specific data on the three subgroups, groups IA, 1B, and
2A, with recent macroscopic hematuria and/or greater than
1,000,000 red blood cells/mi are shown in Tables 2, 3, and 4.
Examples of the histologic lesions found in patients with
macroscopic hematuria are shown in Figures 1, 2, and 3. A
segmental hyalinosis and sclerosis lesion is shown in Figure 4.
There were no statistically significant differences in the
extent of proteinuria between any of the groups or subgroups
although patients with more severe hematuria tended to have
higher daily protein excretion. Likewise, the percentage of
patients with hypertension did not differ. In biopsy specimens
with crescents the number of glomeruli involved in this process
on a percentage basis did not differ among groups or subgroups.
However, biopsy specimens from all of the subgroups with
macroscopic hematuria or greater than 1,000,000 red blood
cells/mi urine at the time of biopsy had a high percentage of
patients who had crescentic disease (70 to 100%) as compared
to 36.2 and 18.6% in biopsy specimens from groups 1 and 2 as a
whole. The percentage of glomeruli that were obsolescent or
totally sclerotic did not differ between patients with and without
macroscopic hematuria. There were no differences in the semi-
quantitative scores of vascular and interstitial fibrosis between
groups 1 and 2 patients.
The type of immunoglobulin deposition in renal biopsy speci-
mens did not differ between the groups. C3 was present in
virtually all biopsy specimens along with IgA in a mesangial
distribution. 1gM was the next more frequent immunoglobulin,
being present in 71% of biopsy specimens followed by fibrin
37%, IgG 16%, and Clq 11%.
Few patients during macroscopic hematuria or at times when
red cell counts in the urine were greater than 1 ,000,000/ml had
immune complexes or serum IgA determined. In patients who
had these investigations, there were no differences between
groups. Twenty-nine percent of the biopsy specimens in pa-
tients with a history of macroscopic hematuria in whom im-
mune complexes were measured had positive studies compared
to 50% of the biopsy specimens in patients without macroscopic
hematuria.
Likewise elevation serum IgA was noted in 31 and 18% of
groups I and 2 patients, respectively, in whom these studies
were done. This difference was not statistically significant.
Discussion
Various histologic patterns have been found on light micros-
copy in large series of patients with mesangial IgA nephropathy
[3—61. Results of this study suggest that focal and segmental
proliferation are associated in a high percentage of patients with
macroscopic hematuria and focal crescent formation. When this
lesion heals the glomerulus often shows changes of focal and
segmental hyalinosis/sclerosis. Patients with similar glomerular
immunofluorescence but with only diffuse mesangial prolifera-
tion on light microscopy have less hematuria and few, if any,
crescents.
It is our understanding that the failure of previous studies to
recognize this clinicopathologic correlation may be due in part
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Fig. 4. Segmental hyalinosis-scierosis lesion
which appears during the healing phase after
crescent formation. (Silver Masson >< 900)
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Number of biopsies 116
Serum creatinine at
presentation, /Lmoles/liter
normal < /10 imolesI1iter 240 20
Creatinine clearance at
presentation, mi/mm; normal,
90 to /30 mi/mm 69 36
Daily protein excretion, normal
<0.1 g/day 1.4 1.1
% Patients with blood pressure
> 150/100 36
Serum IgA > 4 mg/mI 12 of 39 biopsies 4 of 22 biopsies
Cl binding > 4% 7 of 24 biopsies 8 of 16 biopsies
% Biopsy specimens with
crescents 36.2
% Biopsy specimens with focal
and segmental proliferation 35.9
% Biopsy specimens with focal
and segmental hyalinosis/
sclerosis 35.4
% Patients presenting with
renal failure serum creatinine
> 300 p.moles/liter or <45
mi/mm 22.5
a Values listed are means so or percentages. The extent of
statistical significance is noted by footnotes b and c. When no footnote
is present, differences between groups I and 2 were not significantly
different at P < 0.05.
b P < 0.01.
P < 0.05.
d Serum creatinine: 1 mg/dl = 88 moles/liter.
to the focal nature of the active phase of this disease process.
More likely, however, is the proximity of our renal biopsies to
the episode of clinical bleeding in groups 1A and lB patients in
our study. Gartner et al [41 found that only 6% of 37 patients
presenting with macroscopic hematuria had crescents, howev-
er, the precise timing of the biopsy in relation to an episode of
hematuria is unclear. Moreover, the method of quantitating
urinary red cells used 20 as the number of cells per high power
field defining severe hematuria. Previous data have shown that
patients with 20 red blood cells per high power field may have
between 10,000 and 100,000 red blood cells per milliliter, thus
not necessarily displaying the extent of hematuria as in our
patients [8]. The patients of Gartner eta! also had normal serum
creatinine measurements, and only 13 of 153 patients in his total
series were biopsied again [4]. Clarkson et al could find no
differences in biopsies of patients in exacerbation or remission
in regard to macroscopic hematuria [31. No data were presented
concerning the timing of biopsies or the quantification of
hematuria in these individuals. Thus, qualitative estimates of
hematuria may be misleading, possibly leading to differing
interpretations regarding the severity of bleeding and the impor-
tance of any associated proteinuria as predictors of a poorer
prognosis.
Crescents and proliferation may disappear within a matter of
weeks leaving hyalinotic and sclerotic lesions as their only
residua [9]. Thus, patients who had biopsies more than 30 days
following an episode of macroscopic hematuria had a much
lower prevalence of crescents and proliferative lesions and
higher prevalence of hyalinosis and sclerosis.
It should be noted that patients without macroscopic hematu-
na on whom biopsies were performed when urinary red cells
were greater than 1,000,000/mi show similar morphologic
changes to patients with macroscopic hematuria. If these pa-
tients had been excluded from an analysis of the total group of
patients without macroscopic hematuria, differences between
groups I and 2 obviously would be even more striking. Previous
reports concerning the importance of macroscopic hematuria
may have excluded patients who quantitatively had large num-
bers of urinary red cells by relying only on history. Examination
of the urinary sediment quantitatively is both cheap and simple.
The presence of more than 1,000,000 red cells/mi urine strongly
suggests that the underlying glomerular disease is active and
that crescentic change is likely. In addition, by examining
the sediment with phase contrast microscopy, confirmation
of the glomerular origin of the hematuria may be obtained [10,
lii.
Follow-up studies of patients with mesangial IgA nephrop-
athy are relatively short-term [3, 5, 61 or contain small numbers
of patients [1, 2, 4, 121. In the report of Hood et al, five of 37
patients developed renal failure over a mean follow-up of less
than 3 years [51. Although few patients had segmental necrosis
or crescents on the initial biopsy, 78% of these patients experi-
enced single or repeated episodes of macroscopic hematuria.
The timing of renal biopsies to episodes of macroscopic hema-
tuna was not stated. Berger, who initially described mesangial
IgA nephropathy in 1969 [131, recently revised his earlier
optimistic view of prognosis concluding that as many as one
third of mesangial IgA patients will ultimately develop renal
insufficiency [14]. The numbers of patients with crescentic
change on initial biopsy or at times of macroscopic hematuria is
unknown.
If crescents accompany various morphologic types of glomer-
ulonephritis, the prognosis is thought to be worse [15, 16]. If
more than 80% of glomeruli are involved by crescents, progres-
sion to renal failure usually proceeds rapidly. It is possible that
development of renal failure depends on the extent, frequency,
and severity of cycles of segmental proliferation, necrosis and
crescent formation. The patients with IgA nephropathy and
episodes of macrohematuria have the potential for this type of
course based on biopsy findings at the time of heavy bleeding.
The pathogenesis of mesangial IgA nephropathy and its
subsequent progression of renal failure is unknown [171. Al-
though elevated serum IgA levels theoretically might play some
role as was suggested by Hood et al [5], a controlled trial of
phenytoin which lowered serum IgA levels to normal failed to
affect disease progression [18]. Moreover, our study and others
show that only 30 to 50% of patients have elevated circulating
IgA concentrations [3, 16].
Table 1. Comparison of patients with or without history of
macroscopic hematuriaa
Group 1 Group 2
Number of patients 40 39
70
140 14"
87 30c
1.0± 1.2
28
l8.6b
24.3
40
SIC
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Table 2. Patients (subgroup 1A) with mesangial IgA nephropathy biopsied during an episode of macroscopic hematuriaa
Serum 24-hr
Glomeruli creatinine Creatinine Blood Protein
Patient Histologic Crescents sclerosed moles/ clearance pressure excretion
no. Age/Sex pattern % % liter mI/mm mm Hg grams
1 39 F DMP; FSP;
FSH-Sc
27 18 140 47 132/70 4.3
2 56 F DMP; FSP 17 33 210 40 155/105 2.4
3 17 M DMP; FSP
DMP; FSP
5
6
18
20
80
70
126
126
160/100
136/80
0.8
1.1
4 15 M DMP; FSP 12 0 90 108 125/75 1.2
5 61 M DMP; FSP
DMP; F5H-5c
6
10
45
43
820
900
9
6
135/95
140/100
0.4
0.1
6 27 M DMP; FSP 20 10 90 144 128/82 1.7
7 50 M DMP; FSP 40 0 700 .4 160/90 1.2
8 37 M DMP; FSP 13 25 110 90 180/1 10 2.0
9 19 M DMP; FSP 12 10 350 24 130/85 1.5
10 37 M DMP; FSH-Sc 11 11 350 27 175/112 0.7
11 22 F DMP; FSP 33 0 105 60 160/110 2.5
Total mean SD 18 13 16 14 290 20 72 66 1.7 1.1
Abbreviations: DMP, diffuse mesangial proliferation; FSP, focal and segmental proliferation; FSH-Sc, focal and segmental hyalinosis/scierosis.
a One hundred percent of the biopsy specimens had focal and segmental crescent formation. Two patients presented with severe renal failure.
Table 3. Patients (subgroup I B) with mesangial IgA nephropathy who had biopsies within 3 to 27 days of macrohematuriaa
24-hour
Patient
no. Age/Sex
Histologic
pattern
Crescents
%
Glomeruli
sclerosed
%
Serum
creatinine
p.moles/liter
Creatinine
clearance
ml/min
Blood
pressure
mm Hg
Protein
excretion
grams
12 45 M DMP;FSP 20 0 110 88 128/80 0.8
13 30 M DMP; FSP 5 40 90 72 155/105 1.2
14 19 M DMP;FSP 0 0 80 66 110/60 0.1
15 35 M DMP 8 33 90 72 165/115 3.4
16 31 F DMP; FSP 8 17 80 60 125/85 0.2
17 18 M Diffuse
endocapillary
proliferation
11 0 100 22 150/100 0.7
18 29 M DMP; FSP;
FSH-Sc
4 83 320 30 168/108 0.2
19 33 M DMP; FSP
DMP; FSP;
FSH-Sc
13
13
13
18
100
110
138
120
170/100
140/95
1.9
1.5
20 17 M DMP; FSP 9 0 600 24 115/65 1.2
21 42 F DMP; FSP 100 10 900 6 185/125 0.1
Total mean SD 17 28 14.5 25 230 270 58 42 1.2 1.0
Abbreviations: DMP, diffuse mesangial proliferation; FSP, focal and segmental proliferation; FSH-Sc, focal and segmental hyalinosis/sclerosis.
a Less than 106 red cells are present per milliliter of urine. Ninety-one percent of the biopsy specimens had focal and segmental crescent
formation. Two patients presented with severe renal failure.
Circulating or in situ immune complex formation is more
likely to play a role in initiating and maintaining tissue injury.
Woodroffe et al were able to find circulating immune complexes
in 64% of episodes of macroscopic hematuria [191. We have too
few data during acute episodes to corroborate this, however, it
is clear that positive tests may occur in such patients at times
when hematuria is not excessive. Variations in the pathogenesis
and course of the mesangial IgA syndrome from various centers
could be due to different types of complexes formed by certain
individuals in response to disparate infectious or environmental
antigens. It is interesting to note the relatively high percentage
of biopsy specimens containing IgG in Europe and North
America [4, 5, 13, 20] in contrast to the Australian biopsy
specimens in which 1gM is the most common immunoglobulin
found accompanying C3 and IgA [3, 191.
Based on the clinical and histologic observations in this
study, we would suggest that focal breaks in the glomerular
basement membrane as a result of segmental proliferation lead
to crescent formation. Consistent with this formulation are the
observations of Kupor, Mullins, and McPhaul [21], Shigematsu
et al [221., and Sakai, Kitajima, and Kawamura [23] who
reported segmental tuft adhesions and crescents in from 17 to
30% of the biopsy specimens in patients with idiopathic renal
hematuria and IgA nephropathy. Shigematsu et al [22] demon-
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Table 4. Patients (subgroup 2A) without macroscopic hematuria but with >106 red cells/mi urinea
24-hour
Patient
no. Age/Sex
Histologic
pattern
Crescents
%
Glomeruli
scierosed
%
Serum
creatinine
moles/liter
Creatinine
clearance
mi/mm
Blood
pressure
mm Hg
Protein
excretion
grams
22 36 M DMP; FSP 8 42 170 57 185/115 0.5
23 23 F DMP; FSH-Sc 0 0 80 84 122/78 3.8
24 49 M DMP; FSP ii 33 190 45 135/85 0.2
25 28 F DMP; FSP 25 58 160 52 65/115 3.4
26 29 F DMP 0 40 50 174 105/70 0.4
27 28 M DMP; FSP 7 13 160 90 140/90 0.3
28 44 M DMP; FSH-Sc 15 10 80 104 128/84 0.8
29 25 F DMP; FSH-Sc 44 8 80 54 136/88 1.2
30 45 M DMP; FSP;
FSH-Sc
50 23 700 6 165/1 10 4.0
31 48 M DMP; FSP;
FSH-Sc
0 45 190 42 130/85 3.5
32 18 M DMP; FSP 5 10 60 120 150/105 1.5
33 64 M DMP; FSP
FSH-Sc
100 50 800 6 165/105 0.6
34 37 F DMP; FSP
DMP; FSP
15
52
40
44
100
280
66
36
125/75
130/85
4.0
2.0
Total mean SD 25 32 31 20 340 50 64 48 1.9 1.6
Abbreviations are as in Table 3.
a Seventy-nine percent of the biopsy specimens had crescent formation. Two patients presented with renal failure severe enough to require
dialysis.
strated that focal breaks in the glomerular basement membrane
with fibrin and red cells demonstrable in Bowman's space are
associated with focal and segmental proliferative lesions and
crescents in IgA nephropathy. Similar changes have been noted
in association with crescents in other giomerulopathies [24, 25].
The pathophysiologic mechanism resulting in reversible de-
clines in glomerular filtration rate is less clear. Recent data
suggest that glomerular bleeding per se may result in morpho-
logic evidence of tubular injury and intratubular obstruction
[261.
Thus, mesangial IgA nephropathy associated with recent
macroscopic hematuria and/or more than 1,000,000 red blood
cells/mi urine carries a high likelihood of focal and segmental
proliferative changes with crescents on renal biopsy specimens.
In patients without recent macroscopic hematuria and less than
1,000,000 red cells/mi, the presence of focal and segmental
sclerosis and hyalinosis most likely represents a healing stage of
a prior proliferative lesion. Episodes of macroscopic hematuria
are often associated with renal dysfunction which are frequent-
ly reversible. In management of patients with mesangial IgA
nephropathy quantitative assessment of renal bleeding may
provide useful information.
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